Switch to
More onapp

How to use scorecard? Learn more

Alkem Laboratories Ltd

ALKEM
Health CarePharmaceuticals
MidcapWith a market cap of ₹74,060 cr, stock is ranked 132
Low RiskStock is 1.94x as volatile as Nifty
6,137.80156.30 (-2.48%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹74,060 cr, stock is ranked 132
Low RiskStock is 1.94x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
36.05
PB RatioPB Ratio
6.91
Dividend YieldDiv. Yield
0.65%
Sector PESector PE
51.22
Sector PBSector PB
6.55
Sector Div YldSctr Div Yld
0.48%

Forecast & RatingsDetailed Forecast 

42%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

Brands

Alkem Labs

Pharmaceutical company

Brands

Alkem Labs

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320249.1010.8011.8212.981.591.650.981.80
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.80%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent 
Announced OnOct 9, 2024

ALKEM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | Download

ALKEM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | Download

Appointment 
Announced OnOct 9, 2024

Alkem Laboratories Limited has informed the Exchange regarding Appointment of Mr Ashish Kumar Suresh at Senior Management Position of the Company w.e.f. October 09, 2024. | Download

Alkem Laboratories Limited has informed the Exchange regarding Appointment of Mr Ashish Kumar Suresh at Senior Management Position of the Company w.e.f. October 09, 2024. | Download

Cash Dividend 
Ex. DateAug 9, 2024

Final • Div/Share: ₹ 5

See all events